LET'S STAY IN TOUCH

We’d love to keep you updated with all of the latest news about TAKHZYRO, as well as helpful information about living with HAE. Are you in?

*Required fields.

First Name*

Last Name*

Email Address*

Which best describes you?*

I have not been diagnosed with HAE I have been diagnosed with HAE I have a loved one with HAE

What best describes your current HAE treatment plan?

Acute only Preventive only Both acute and preventive I’m not currently treating

Address 1

Address 2

City

ZIP Code

State

Yes, I am interested in receiving information from Takeda via the contact information provided above.*

By clicking “Submit” I certify that I am 18 years of age or older.

By providing your information, you consent to receiving marketing and promotional communications and other information from Takeda. You hereby give consent to Takeda, its affiliates, and their agents and representatives to send communications and information to you via the contact information you have provided above. This consent will be in effect until such time as you opt out of communications from Takeda. If, at any time, you no longer wish to receive communications from Takeda, you can opt out by calling 1-866-888-0660. Please see our privacy policy.

WHAT IS TAKHZYRO?

TAKHZYRO is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in people 12 years of age and older.

It is not known if TAKHZYRO is safe and effective in children under 12 years of age.

IMPORTANT SAFETY INFORMATION

TAKHZYRO may cause serious side effects, including allergic reactions. Call your healthcare provider or get emergency help right away if you have any of the following symptoms:

wheezing
difficulty breathing
chest tightness
fast heartbeat
faintness
rash
hives

The most common side effects seen with TAKHZYRO were injection site reactions (pain, redness, and bruising), upper respiratory infection, and headache.

These are not all the possible side effects of TAKHZYRO. For more information, ask your healthcare provider or pharmacist. You may report side effects to the FDA at 1-800-FDA-1088.

TAKHZYRO has not been studied in pregnant or breastfeeding women. Talk to your healthcare provider about the risk of taking TAKHZYRO if you are pregnant, plan to be pregnant, are breastfeeding, or plan to breastfeed.

Please see full Prescribing Information, including information for patients.